Russia’s announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA technology shows potential, the lack of clinical data and the gap between preclinical and human trials raises concerns. Only through rigorous research and trials will we know if this vaccine can truly transform cancer care, inform experts., Russia’s announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA technology shows potential, the lack of clinical data and the gap between preclinical and human trials raises concerns. Only through rigorous research and trials will we know if this vaccine can truly transform cancer care, inform experts., , Read More

AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way